Population
Patients with chronic congestive heart failure (CHF)
Design
Review
Authors
Loading...
Reinforces ACE inhibitor benefits in heart failure; raises methodological and ethical questions for future trial designs.
This review highlights the historical evolution of CHF clinical trials, noting the comprehensive benefits of ACE inhibitors and raising critical methodological and ethical questions for future trial designs.
Carl V. Leier (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: